Post-earnings recap
Reported
Tue, Mar 12, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report indicates that ACADIA Pharmaceuticals did not meet earnings expectations, resulting in a 2.62% decline in stock price. The lack of revenue figures and guidance may raise concerns among investors about the company's future performance. Overall, the market reacted negatively, reflecting uncertainty about the company's direction.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.11 | N/A | -34.15% |
| Revenue | N/A | N/A | N/A |
Management expressed concerns about the current market conditions impacting performance. They did not provide any forward-looking guidance.
Management did not provide specific revenue guidance for the upcoming quarters.
The company acknowledged challenges in meeting earnings expectations.